New minimally invasive procedure for mitral regurgitation
Mitral regurgitation is a common heart valve disease with a poor prognosis once severe and symptomatic. Mitral regurgitation forces the heart to work harder to pump blood which can lead to an enlarged heart or other serious heart problems, including heart failure.
If at high risk for traditional open-heart surgical intervention, your patient may be a candidate for minimally invasive transcatheter mitral valve repair or TMVR at Gundersen.
Unlike surgery, TMVR does not require opening the chest. Gundersen heart specialists can access the mitral valve using a catheter threaded through a vein in the groin up to the heart. The catheter carries a small device called a MitraClip® that's implanted to tighten the mitral valve so it can close more completely and reduce the amount of mitral regurgitation.
While the TMVR procedure is less invasive than traditional open-heart surgery, it is not right for everyone. But for eligible patients, TMVR offers many benefits over traditional surgery. In clinical studies patients experienced:
- An immediate reduction in mitral regurgitation
- Low hospital length of stay of 2.9 days on average
- More than 70 percent reduction in hospital visits for heart failure
- Improved quality of life soon after the procedure
To help determine the best course of treatment for your patient with significant mitral regurgitation, consider a referral to the Gundersen Valve Clinic. Through the clinic, a multi-disciplinary heart valve team will evaluate your patient, conduct further testing as indicated and make recommendations for treatment.
To make a referral for your patient to the Gundersen Valve Clinic or to speak to one of our Valve Clinic coordinators call via MedLink at (800) 336-5465 of in La Crosse at 775-5465.